What Bionano Genomics, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 2 | 2 |
| Sells | 0 | 0 |
| Total trades | 2 | 11 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 8,000 | 8,000 |
| Disposed | 0 | 180 |
| Net activity | +8,000 | +7,820 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Luderer Albert | Interim Chief Executive | Sep 04 | Open-market buy · P | +4,000 | $1.21 | +$4.84K | 8,000 |
| Luderer Albert | Interim Chief Executive | Aug 21 | Open-market buy · P | +4,000 | $1.22 | +$4.86K | 4,000 |
| Adamchak Mark | Principal Accounting Officer | Jun 03 | Withheld — tax / exercise cost · F | −7 | $1.30 | −$9.1 | 253 |
| Chaubey Alka | CHIEF MEDICAL OFFICER | Jun 03 | Withheld — tax / exercise cost · F | −24 | $1.30 | −$31.2 | 620 |
| Borodkin Mark | CHIEF OPERATING OFFICER | Jun 03 | Withheld — tax / exercise cost · F | −27 | $1.30 | −$35.1 | 868 |
| Dixon Jonathan V. | GENERAL COUNSEL | Jun 03 | Withheld — tax / exercise cost · F | −24 | $1.30 | −$31.2 | 239 |
| Dixon Jonathan V. | GENERAL COUNSEL | Feb 17 | Withheld — tax / exercise cost · F | −6 | $1.10 | −$6.6 | 263 |
| Borodkin Mark | CHIEF OPERATING OFFICER | Feb 17 | Withheld — tax / exercise cost · F | −20 | $1.10 | −$22 | 895 |
| Adamchak Mark | Principal Accounting Officer | Feb 17 | Withheld — tax / exercise cost · F | −3 | $1.10 | −$3.3 | 260 |
| Chaubey Alka | CHIEF MEDICAL OFFICER | Feb 17 | Withheld — tax / exercise cost · F | −18 | $1.10 | −$19.8 | 644 |
| Holmlin R. Erik | PRESIDENT AND CEO | Feb 17 | Withheld — tax / exercise cost · F | −51 | $1.10 | −$56.1 | 1,657 |
| Chaubey Alka | Chief Medical Officer | Sep 11 | Withheld — tax / exercise cost · F | −51 | $4.06 | −$207 | 662 |
| Borodkin Mark | Chief Operating Officer | Sep 11 | Withheld — tax / exercise cost · F | −59 | $4.06 | −$240 | 915 |
| Chaubey Alka | Chief Medical Officer | Jun 03 | Withheld — tax / exercise cost · F | −24 | $3.69 | −$88.6 | 713 |
| Dixon Jonathan V. | General Counsel | Jun 03 | Withheld — tax / exercise cost · F | −25 | $3.69 | −$92.3 | 269 |
| Borodkin Mark | Chief Operating Officer | Jun 03 | Withheld — tax / exercise cost · F | −27 | $3.69 | −$99.6 | 974 |
| Adamchak Mark | Principal Accounting Officer | Jun 03 | Withheld — tax / exercise cost · F | −7 | $3.69 | −$25.8 | 263 |
| Holmlin R. Erik | President and CEO | Jun 03 | Withheld — tax / exercise cost · F | −75 | $3.69 | −$277 | 1,708 |
| Holmlin R. Erik | President and CEO | Mar 14 | Withheld — tax / exercise cost · F | −198 | $3.47 | −$687 | 1,783 |
| Adamchak Mark | Principal Accounting Officer | Feb 15 | Withheld — tax / exercise cost · F | −4 | $5.73 | −$22.9 | 270 |
Loading...